5 Ipilimumab

Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii

Published: Dec 12, 2025

Updated: May 20, 2026

Source: TED - Tenders Electronic Daily (EU)

This tender has been awarded

Awarded to Urtica Sp. z o.o. — €285,736,526

Browse open Health & Medical tenders in Poland

About This Opportunity

Award notice from Dolnośląskie Centrum Onkologii (Poland) — 5 Ipilimumab. healthcare. Awarded to Urtica Sp. z o.o. (PLN 285.7M).

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

This tender, originating from Poland and published via the TED (Tenders Electronic Daily) platform, seeks the procurement of Ipilimumab, a crucial pharmaceutical product. Specifically, the requirement is for vials of Ipilimumab, with each vial containing 50 mg of the active substance.

This procurement falls under the category of medical supplies and pharmaceuticals, essential for healthcare services.

The contracting authority, managed by the Publications Office of the European Union, is looking to establish a reliable supply of this medication. Ipilimumab is a type of monoclonal antibody used in the treatment of certain cancers, making its consistent availability vital for patient care.

Typical requirements for such a tender would include stringent quality control measures, adherence to Good Manufacturing Practices (GMP), and compliance with all relevant European Union and national pharmaceutical regulations. Suppliers are expected to demonstrate their capacity to provide the specified quantity of Ipilimumab in the required packaging, ensuring product integrity and stability throughout the supply chain. Furthermore, bidders will likely need to provide comprehensive documentation, including product specifications, certificates of analysis, and evidence of regulatory approval. The tender process will assess not only the technical suitability of the product but also the financial stability and logistical capabilities of potential suppliers to meet ongoing demand within Poland.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on December 12, 2025. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii

Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii has issued 37 procurement notices on BidsFactory, including 1 currently open and 15 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU) and Poland e-Zamówienia. Most recent publication: May 18, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to Urtica Sp. z o.o.. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

Urtica Sp. z o.o. was awarded the contract for €285,736,526. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.